Cargando…
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
The past decade and a half has been characterized by numerous emerging infectious diseases. With each new threat, there has been a call for rapid vaccine development. Pathogens such as the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the Zika virus represent either new viral entities...
Autor principal: | Maslow, Joel N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718785/ https://www.ncbi.nlm.nih.gov/pubmed/28846484 http://dx.doi.org/10.1080/21645515.2017.1358325 |
Ejemplares similares
-
Assay Challenges for Emerging Infectious Diseases: The Zika Experience
por: Roberts, Christine C., et al.
Publicado: (2018) -
Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018) -
Vaccine development for emerging virulent infectious diseases
por: Maslow, Joel N.
Publicado: (2017) -
The cost and challenge of vaccine development for emerging and emergent infectious diseases
por: Maslow, Joel N
Publicado: (2018) -
Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019)